Walgreens Boots Alliance (NASDAQ:WBA) Price Target Raised to $10.00

Walgreens Boots Alliance (NASDAQ:WBA) had its price objective upped by UBS Group from $9.00 to $10.00 in a research note issued to investors on Thursday morning, Benzinga reports. The firm currently has a neutral rating on the pharmacy operator’s stock.

WBA has been the subject of a number of other research reports. Bank of America cut their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Royal Bank of Canada cut their target price on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Truist Financial lowered their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Barclays upped their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Finally, JPMorgan Chase & Co. decreased their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $13.38.

Walgreens Boots Alliance Trading Up 1.2 %

Walgreens Boots Alliance stock opened at $10.79 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.31 and a current ratio of 0.68. Walgreens Boots Alliance has a fifty-two week low of $8.22 and a fifty-two week high of $27.05. The stock has a market cap of $9.33 billion, a P/E ratio of -1.08, a PEG ratio of 1.37 and a beta of 0.70. The firm’s fifty day moving average price is $9.41 and its 200-day moving average price is $13.06.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.67 EPS. Equities research analysts forecast that Walgreens Boots Alliance will post 1.57 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Walgreens Boots Alliance

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vest Financial LLC increased its position in shares of Walgreens Boots Alliance by 27.6% in the third quarter. Vest Financial LLC now owns 133,338 shares of the pharmacy operator’s stock valued at $1,195,000 after acquiring an additional 28,814 shares during the period. V Square Quantitative Management LLC increased its holdings in Walgreens Boots Alliance by 95.1% during the 3rd quarter. V Square Quantitative Management LLC now owns 47,327 shares of the pharmacy operator’s stock valued at $424,000 after purchasing an additional 23,071 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Walgreens Boots Alliance by 2.0% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 67,016 shares of the pharmacy operator’s stock valued at $600,000 after purchasing an additional 1,326 shares during the period. B.O.S.S. Retirement Advisors LLC raised its position in Walgreens Boots Alliance by 25.2% during the 3rd quarter. B.O.S.S. Retirement Advisors LLC now owns 66,542 shares of the pharmacy operator’s stock valued at $596,000 after purchasing an additional 13,383 shares during the last quarter. Finally, Twelve Points Wealth Management LLC lifted its holdings in Walgreens Boots Alliance by 159.8% in the 3rd quarter. Twelve Points Wealth Management LLC now owns 35,254 shares of the pharmacy operator’s stock worth $316,000 after buying an additional 21,684 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.